• BioAdaptives announced November 4, 2026, it will issue Economic Preferred to Xycota Biosciences' founders for 100% of its membership interests.
• The Economic Preferred will represent 40% of total voting power and economic ownership immediately upon issuance.
• Investors will receive convertible promissory notes for cash at a 10% original issue discount.
• The securities will be issued without registration under Section 4(a)(2) of the Securities Act, with no underwriting discounts or commissions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioAdaptives Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001640334-26-001712), on November 04, 2026, and is solely responsible for the information contained therein.